GloPID-R is a unique international network of major research funding organizations.
Together, we facilitate a rapid and effective response to infectious disease outbreaks.
Our Work
Our aim is to invest in research capacity and capabilities to support the rapid initiation of scientific research in case of an outbreak.
Clinical Trial
Networks
Hear from the experts on topics such as social science, data sharing, capacity building, and EARL barriers.
Read more29 members
Since its creation in 2013, GloPID-R has steadily increased its membership. Today, it consists of 29 members worldwide. The World Health Organization, the Coalition for Epidemic Preparedness Innovations (CEPI) and the European & Developing Countries Clinical Trials Partnership (EDCTP) are also actively engaged in the network.
All membersLatest news
All newsGloPID-R News & Events Round-Up
28/07/2021Welcome to the first issue of our News & Events Round-Up. This selection of recent news items is designed to...
Read moreWhere to next? Crucial insights on trends and gaps for future research funding in the long battle against COVID-19
05/07/2021Researchers and funders around the world can tap into the latest trends and gaps for future COVID-19 research to funnel...
Read moreLatest newsletter from APPRISE & Professor Sharon Lewin appointed President of the Scientific Advisory Board of French ANRS | Emerging Infectious Diseases
29/06/2021Australia’s APPRISE Centre of Research Excellence has published its latest newsletter today with an update of its work and response...
Read moreResources
GloPID-R publishes funding opportunities related to infectious diseases and shares its expertise through its publications and webinars.
All resources